CGEM Cullinan Management, Inc.

Cullinan Management is advancing a growing portfolio of innovative, early-stage clinical therapeutic assets by capitalizing on the latest scientific breakthroughs. We combine a unique portfolio model with innovative sourcing techniques and drug development expertise to discover and advance candidates for potentially transformative oncology drugs.

$12.95  +0.13 (1.01%)
As of 07/01/2022 15:59:57 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/13/2009
Outstanding shares:  44,782,502
Average volume:  369,303
Market cap:   $574,111,676
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BM90J52

---

Valuation   (See tab for details)

---

PE ratio:   -17.81
PB ratio:   1.38
PS ratio:   -30.34
Return on equity:   -2.89%
Net income %:   0.00%